# Ningbo Medsun Medical Co., Ltd.

- Location (FDA's records): Ningbo, CN
- FDA decisions: 7 (2022–2026): 7 510(k) clearances
- Product codes: FMK (4), FMI (2), QRK (1)
- 510(k) review time since 2016: median 94 days, against 68 for FDA's reviews in the same codes and years (2 of 7 faster)
- Predicates its devices cite: 9 (2 its own); citations of its devices by later devices: 2 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Jiangsu Caina Technology Co., Ltd.: 1 (https://510kreport.com/company/jiangsu-caina-technology)
- Jiangsu Caina Medical Co.,Ltd: 1 (https://510kreport.com/company/jiangsu-caina-medical)
- Sandstone Medical (Suzhou), Inc.: 1 (https://510kreport.com/company/sandstone-medical-suzhou)
- Promisemed Hangzhou Meditech Co., Ltd.: 1 (https://510kreport.com/company/promisemed-hangzhou-meditech)
- Medipurpose Pte., Ltd.: 1 (https://510kreport.com/company/medipurpose)
- Tianjin Huahong Technology Co., Ltd.: 1 (https://510kreport.com/company/tianjin-huahong-technology)
- SteriLance Medical (Suzhou), Inc.: 1 (https://510kreport.com/company/sterilance-medical-suzhou)

## Its most-cited devices
- K222090: Safety Lancet (2022), cited by 2

## Recent decisions
- K253622: Safety Pen Needle (Mar 18, 2026)
- K253605: Safety Heel Lancet (Feb 20, 2026)
- K242627: Safety Lancet (Oct 30, 2024)
- K242316: Safety Lancet (Aug 28, 2024)
- K232330: Lancing System (Jan 4, 2024)
- K221178: Disposable Insulin Pen Needle (Nov 17, 2022)
- K222090: Safety Lancet (Sep 30, 2022)

Source page: https://510kreport.com/company/ningbo-medsun-medical